NextCure, Inc. (NXTC)

Last Closing Price: 7.82 (2026-09-04)

Return on Equity (Quarterly)

Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity

NextCure, Inc. (NXTC) had Return on Equity of -122.58% for the most recently reported fiscal quarter, ending 2026-06-30.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
--
$-14.89M
--
--
$15.09M
$-15.09M
$0.20M
$-14.89M
$-14.89M
$-14.89M
$-14.89M
$-14.89M
$-14.89M
$-15.09M
$-14.86M
5.31M
5.31M
$-2.80
$-2.80
Balance Sheet Financials
$22.25M
$0.28M
$0.36M
$22.62M
$6.41M
--
$4.06M
$10.47M
$12.15M
$12.15M
$12.15M
4.07M
Cash Flow Statement Financials
$-23.08M
$11.09M
$1.27M
$25.98M
$15.26M
$-10.72M
$0.65M
--
--
Fundamental Metrics & Ratios
3.47
--
--
--
--
--
--
--
--
--
--
$-23.08M
--
--
--
--
--
--
--
Return on Equity
-122.58%
-122.58%
-65.84%
-122.58%
$2.99
$-4.35
$-4.35